| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |